Improved domestic animal productivity is necessary in order to provide for an increasing world population over the next two to three decades and such improvement would be aided by an increase in the ef®ciency of nutrient utilization. This can be achieved by conventional genetic selection protocols but progress by this approach is slow. A more rapid but as yet largely unproven technique is the direct modi®cation of the genome which can be achieved by the transfer of recombinant DNA to the nuclei of early embryos. This new technology is potentially powerful because it allows the direct transfer of genes without regard to inter-species barriers to breeding. However, it raises a new set of problems associated with the integration and expression of the foreign genetic information in the new genome. In this review the application of the technology to increasing nutrient utilization and increased productivity are discussed. Two areas have received substantial attention in the 15 years since the technique was ®rst applied to domestic animals. First, the current status of the modi®cation of growth hormone levels to improve productivity and feed utilization ef®ciency is reviewed, with current results suggesting that several of the projects may soon be approaching ®eld trial status.
Introduction
Domestic animal production is important to the immediate and long-term future of the human condition, providing as it does vital supplies of food and other products. It is therefore of some concern that the resources needed to support current levels of production are becoming increasingly strained by a burgeoning human population and a limited global carrying capacity. If current trends continue, a crisis in animal production appears inevitable (Brown, 1997) , and our options for alleviating it are limited. The most attractive approach in the longer term is to reduce our overall dependence on animal products, but this will require major changes to lifestyle and social structure. A more immediate option is to increase production ef®ciency, a critical component of which is the ef®ciency with which nutrients are utilized during animal growth and production.
The importance of fully understanding the role of nutrient utilization in animal production enterprises has been recognized for a long time, but the controlling factors are numerous and only partially elucidated. As a further complication, there is a strong link between nutrient supply and intermediary metabolism. It is therefore of no surprise that the relationship between nutrients and production ef®ciency is complex and can sometimes lead to unexpected responses. Since the overall ef®ciency of any particular production-related animal characteristic is under polygenic control, incremental gains are readily achievable by selective breeding from elite animals. The rate of gain that can be achieved by this approach is of the order of 2 ± 4 % per generation (Lindsay, 1998) and since this can be sustained for many generations, the practical outcome for the farmer is a substantial cumulative gain. To give two simple examples, over the past 50 years milk yields from dairy cows have risen from 2000 kg to more than 5000 kg per lactation and the daily liveweight gain of swine has increased from 450 g to more than 800 g (Tribe, 1998) , both largely due to improvements in nutrition and the base genetic stock.
The ef®ciency of nutrient utilization is an important physiological component of the productivity improvement that is possible by conventional genetic selection. However, selective breeding programs do not require an understanding of the genes involved in the targeted production characters. Improvements arise from the selection of more optimal gene combinations identi®ed on the basis of improved phenotypes. The genetic variation that forms the basis of this selection process is derived from random mutation of the parent genomes. The individual mutations generally involve only minor variations in activity between various alleles, and measurable effects on speci®c phenotypes are obtained by producing large numbers of progeny and thus examining many of the possible gene combinations. The approach is inevitably quite slow because each increment of improvement requires a full generation interval. Furthermore, in those instances where a single gene of large effect is identi®ed, it is not possible to transfer such an allele without simultaneously transferring an entire haploid genome from the donor animal because of the limitations imposed by natural mating.
Transgenic technology
With the advent of recombinant DNA techniques, it has become possible to transfer single genes as recombinant DNA between animals and this provides a new dimension to genetic selection techniques, because it then becomes possible to target speci®c genetic properties at the level of the DNA code, instead of utilizing the correlations used in objective selection techniques. However, the¯edgling technology introduces a number of new problems which are summarized below.
Animals that successfully incorporate recombinant DNA into their genomes are de®ned as transgenic and the recombinant DNA itself is known as a transgene. The origins of this extraordinary technology in eukaryotes can be traced back to the experiments of Wigler et al. (1979) who demonstrated that`naked' DNA could be taken up by eukaryotic cells and become part of the functional genome of the`transfected' cells. The ef®ciency of incorporation was low, of the order of 10 73 to 10 74 , but since cell culture methods can provide large numbers of cells, this was not a major technical problem. As the ability to isolate and manipulate genetic information by recombinant DNA techniques matured during the 1970s, it became apparent to a number of laboratories that it might be possible to extend the transfer of recombinant DNA from cultured cells to living organisms if the DNA could be integrated into embryonic cells at a very early stage of development, ideally at the single cell stage. To achieve this, however, a signi®cant increase in transfer ef®ciency was required because such cells could only be obtained in small numbers. The various techniques that have been used to transfer DNA to embryos are brie¯y summarized as follows.
Microinjection
The most commonly used technique for the introduction of foreign DNA into embryonic cells has been that of pronuclei microinjection, although it appears likely that the rapidly emerging technique of nuclear transfer, discussed shortly, may soon replace it. An excellent review of microinjection technology and its history of development is provided by Palmiter & Brinster (1986) and hence its details will only be brie¯y summarized here. The technique was pioneered in laboratory mice and as originally described involved the collection of several hundred single cell embryos obtained from donor animals by conventional reproductive techniques. A small quantity of recombinant DNA was introduced into one of the pronuclei of each embryo by microinjection, involving the insertion of a ®ne needle into the embryo pronucleus and the injection into this organelle of about 2 pl solution. The embryos were then brie¯y cultured and survivors transferred to recipient mothers with reproductive cycles suitably synchronized to accept the embryos. The ef®ciency of the technique increased by several orders of magnitude the integration of foreign DNA into target nuclei compared with that achievable using standard cell culture transfection procedures, although it was nevertheless still an inef®cient process. A summary of eighteen studies involving 12 314 injected mouse embryos gives a ®gure of 2Á6 transgenic animals produced per 100 embryos injected and transferred (Wall, 1996) .
Although minor variations in the procedures are required, the general principles of microinjection developed for mouse embryos are applicable across a wide range of species, including domestic animals. Most of the early work pioneering the application of the technique to domestic animals was carried out by Hammer and colleagues (Hammer et al. 1985) with an emphasis on swine. As more laboratories became involved it became apparent that the ef®ciency of integration of transgenes into most domestic species was substantially lower than that achievable in mice. The transgene integration ef®ciencies per embryo injected are 0Á7 per 100 for cattle, 0Á9 per 100 for swine and sheep (Wall, 1996) . While a detailed study of the factors involved in the optimal incorporation of transgenes into mice has been made , no similar study has been carried out for domestic animals. A major problem in domestic animal embryos is the presence of dense cytoplasmic granules which tend to obscure the pronuclei during the microinjection procedure. While the problem is less apparent in sheep and goats than in pigs and cattle, and can be partially overcome by centrifugation of the embryos before microinjection, it presents dif®culties in all species of larger animals. Whether it is the only factor involved in the lower integration ef®ciencies found in domestic animals is not known.
Mention should also be made of the use of a variant of microinjection in the production of transgenic chickens. This approach has been reviewed in detail elsewhere (Perry & Sang, 1993; Sang, 1994) and consists of microinjecting large quantities of DNA into the cytoplasm of fertilized eggs in the vicinity of the male and female pronuclei and then allowing the eggs to develop using a specialized culture technique. The ®rst generation of chickens produced by this technique are highly mosaic for the integrated DNA but lines of chickens with stable germ-line integrations can be established by normal breeding techniques (Mather et al. 1994; Karapetiyan, 1997) . While this approach has little applicability to large domestic animals, it is an important route at present for the production of transgenic birds. However, recent advances in the use of retrovirus vectors and liposome-mediated transfection are also of value in avian applications, as indicated in the following sections.
Retroviruses
The use of retroviruses to transfer DNA to embryos has been investigated by several groups as a potential route for gene transfer (for review, see Valerio, 1992) . While this route has some attractive features, until recently it has appeared to be of limited application to the production of domestic transgenic animals. However, two novel modi®cations of the technology have recently been reported that may widen its applicability and safety in domestic animals. The general approach involves several discrete steps. Initially, a disabled retrovirus must be constructed that contains a partially functional genome that is missing one or more of the genes required for viral packaging andaor infection. These missing viral components are supplied on a one-off basis by the use of a helper virus. The disabled viral genome must then be modi®ed by integration of the transgene into its sequence. There are some limitations to the size of insert that can be accommodated by retroviruses, with an upper limit of about 10 kb frequently accepted (Gelinas & Temin, 1986) . Once the retroviral nucleotide sequence is constructed, infectious viral particles are produced by incubation of the disabled virus with a helper virus that provides the missing components needed for construction of a fully infectious particle. The infectious virus can then be used to infect cells of the target animal, in principle incorporating itself and the associated transgene into the target genome.
Several problems have been identi®ed with this approach. It is mandatory that the viral sequence carrying the transgene is totally disabled and incapable of producing infectious viral particles on its own, since this would enable uncontrolled spread of the transgene through the target species. There is some debate about how effective the disablement of retroviruses is (Bosselman et al. 1989) . It has also been found that a high level of mosaicism occurs for the integration of the retrovirus, with many transgenic animals not containing the transgene in the germ-line (Stewart et al. 1987) . Expression of the transgene is also unpredictable for reasons as yet undiscovered (Jaenisch, 1988) .
Recently, two novel modi®cations of the retroviral approach have been reported. In the ®rst case, a self-inactivating vector has been designed with the properties of self-excision of the long terminal repeat sequences needed for infection (Hofman et al. 1996) . This should provide signi®cantly greater levels of safety in the use of this process. The second recent modi®cation offers substantially increased ef®ciencies of integration. In this work, a disabled retroviral vector containing a DNA insert was injected directly into cattle oocytes, which are arrested in metaphase II before fertilization (Chan et al. 1998) . The hypothesis put forward by these authors was that the nuclear material was likely to be considerably more accessible to retroviral integration at this time because the nuclear envelope would have broken down as part of the oocyte maturation process. The results appear to support their concepts, since four calves (three female, one male) were born from embryos developed from treated oocytes and all four animals were transgenic. Furthermore, the male animal was shown to contain the transgene in its semen and when oocytes were fertilized with this semen, ®ve of the nine embryos examined were transgenic, indicating proper Mendelian segregation.
It will be of interest to see how effective this can be in ensuring that no infectious viral particles are produced from infected cells, but it would seem likely that a combination of a multiply disabled vector incorporating self-inactivation after integration might prove of adequate safety.
A re®nement of the use of retroviruses is the developing ®eld of transposable elements. These sequences are widely distributed in nature and possess the ability to integrate into target genomes in the same way as for retroviruses. They also have the ability to move between DNA sites within a genome but do not have the infective ability associated with retroviruses. They have been investigated in detail in plants (Federoff et al. 1992) and Drosophila (Sherratt, 1995) but have had little application in animals. Recently, however, the potential for their use in animals has been demonstrated by several studies. The Drosophila element`mariner' has been shown to transpose into fowls at high frequency and provide germ-line transmission in one of three birds that were produced (Sherman et al. 1998) . In another study, a transposable element was`rescued' from the salmonid genome and shown to be capable of integrating into a range of species including mammals (Hackett et al. 1998) . These sequences can be modi®ed to accept a piece of foreign DNA in similar fashion to retroviruses and to integrate this DNA into the target genome together with the essential transposase sequences. Research is still required to demonstrate how effectively such sequences are expressed in their new environment and how stable they are once integrated. However, preliminary reports suggest a high ef®ciency of integration, thus making it an attractive approach for the production of transgenic animals.
Cell culture-based transfection methods
A variety of standard techniques that are commonly used for the transfection of cells in culture have been tested as possible methods for the introduction of genes into embryos, but all have proven to be of too low an ef®ciency to be useful. The methods tested include CaPO 4 -precipitates, cytoplasmic injection, electroporation and liposomes. However, the use of cell transfection has recently assumed greater importance in the production of transgenic animals because of the advent of nuclear transfer (see later). Also, a recent encouraging report has appeared in the production of transgenic chickens. In this work, fowl blastodermal cells were transfected in culture, enriched by FACS-sorting and used to produce chimaeric embryos of which 35 % were germ-line transgenic (Specksnijder et al. 1999) . It is probable that in the near future, most transgenes will be inserted into cells in culture by conventional transfection techniques and the resulting stable lines used to produce transgenic animals.
Sperm-mediated gene transfer
It has been reported that DNA can be carried into oocytes by adsorbing it to spermatozoa and that this DNA is subsequently integrated into the embryo genomes to produce transgenic animals (Brackett et al. 1971; Lavitrano et al. 1989) . The initial excitement produced by these results has subsequently been tempered by the lack of success achieved by many laboratories' attempts to repeat the work . However, reports continue to appear at irregular intervals (Sperandio et al. 1996) indicating that there may yet be some merit in the approach, although it must at this stage be considered an unproven technology.
Gene guns
DNA can be introduced into cells by coating small particles with the transgene of interest and ®ring' the particles into appropriate tissues (Williams et al. 1991) . When this is carried out into somatic tissues, expression of the genes is transient and the transgenes do not integrate into the nuclei of the somatic cells or at least integrate with such low ef®ciency that integration is undetectable (Kerr et al. 1996) . It is theoretically possible that if the procedure was carried out with the reproductive tissues as target, some integration of the transgene might be obtained which could give rise to a transgenic animal. There are no reports that this has been tested experimentally and to date the technique remains of value for measuring transient expression of transgenes in speci®c tissues but is of little value in the production of stable transgenic lines of animals.
Nuclear transfer
The technique that appears poised to supplant microinjection as the preferred method for the introduction of transgenes to domestic animals is the recently developed procedure of nuclear transfer. This offers a signi®cant improvement in the ef®ciency with which transgenic livestock might be produced and in addition has the potential to provide some very useful additional capabilities for the modi®cation of the target genome. In contrast to the microinjection technique, whereby a transgene is added directly to the genome of an embryo, the new technique of nuclear transfer involves the introduction of a transgene to cells maintained in cell culture and the use of one of these cells as a source of genetic information to program the development of an enucleated oocyte (Campbell et al. 1996; Wilmut et al. 1997) . While the mechanism remains poorly understood, it appears that the cytoplasm of the recipient oocyte possesses the ability tò re-program' the DNA of the transformed, cultured cell in such a way that the embryonic developmental program can be commenced from time zero. Based on the pioneering work of Willadsen (1986) , the recent technology has been developed by Campbell et al. (1996) and Wilmut et al. (1997) who have discovered the important role of the cell cycle in the process. In essence, it appears that the ef®ciency of the process is enhanced if the donor cells are placed in the quiescent G 0 stage of the cell cycle by depriving them of serum in their growth medium. Upon transfer to metaphase II enucleated oocytes, the nuclei of these cells are apparently reprogrammed to undergo the full developmental program normally reserved for zygotes derived by sperm-mediated fertilization. A crucial aspect of the recent discoveries is the ®nding that somatic cell lines derived from adult tissue can serve as nuclear donors in this process (Wilmut et al. 1997) , a remarkable ®nding recently con®rmed in laboratory mice (Wakayama et al. 1998) . The technique has also now been extended to the production of transgenic cattle (Cibelli et al. 1998) , indicating its probable wide applicability to many domestic animal species. This latter paper also questions the need for donor cells to be in the G 0 phase of the cell cycle, a crucial ®nding, if con®rmed, since it has signi®cant implications for the intellectual property rights associated with the widespread commercial use of the technology.
There are many clear advantages to the use of nuclear transfer compared with microinjection as a method of introducing transgenes to domestic animals. Since the transgene is ®rst introduced to cells in culture, this overcomes the highly inef®cient and time-consuming step of using fertilized embryos as the target for gene integration. Cultured cells can be obtained in large numbers and recombinant DNA is readily introduced to these cells by a variety of wellproven techniques. Selected cells can be made into clonal lines and evaluated for site and stability of integration and in some cases can even be tested for expression, all under conditions of cell culture, before using them for the production of transgenic animals. In addition, for cells in culture, techniques are available to carry out homologous recombination between the recombinant DNA and the equivalent homologous gene in the target cell, thus allowing speci®c genes to be inactivated or replaced by variant alleles. This adds a powerful new capability to gene manipulation of domestic animals, since the potential is for genes to be added, inactivated or replaced in speci®c animal lines. At its current stage of development, nuclear transfer is still in an experimental phase but it appears well-placed eventually to replace microinjection as the method of choice in introducing transgenes to domestic animals.
Transgenic approaches to the alteration of nutrient utilization
The demonstration by Palmiter et al. (1982 Palmiter et al. ( , 1983 that the phenotype of an animal could be altered by recombinant DNA initiated a range of research programmes directed towards the improvement in production ef®ciency. It is an indication of the dif®culty of the technology and our incomplete understanding of the physiological processes of animals that none of these projects has yet achieved an outcome that enables it to be used at a production level on the farm. Improvements in the gene transfer technology, as described above, may improve the chances of success, but a better understanding of the underlying physiological processes is also crucial. With this in mind, the areas that have been subjected to investigation are reviewed below, together with some comment on the progress that might be expected over the next few years.
Manipulating the endocrine system
The large physiological effects that can be produced by small changes in the levels of circulating hormones make the endocrine system an attractive target for genetic manipulation. To alter body growth, carcass composition and feed utilization ef®ciency, an obvious endocrine target is the suite of peptide hormones comprising growth hormone (GH), growth hormonereleasing factor (GRF), insulin-like growth factor-1 (IGF-1), insulin, and thyrotrophic hormone, because these hormones are widely believed to control body growth and tissue development. The hormone chosen for initial experimentation was GH itself, for two reasons. First, the administration of exogenous GH to animals has been shown to increase feed utilization ef®-ciency, increase growth, and produce a leaner carcass composition (for reviews, see Spencer, 1985; Sejrsen, 1986; Florini, 1998) . Second, the pioneering research of Palmiter et al. (1982 Palmiter et al. ( , 1983 in transgenic mice demonstrated the feasibility of in¯uencing the phenotype of transgenic animals by inserting novel genes into their genomes that altered the circulating levels of GH. In domestic animals the bulk of the early data have been generated in swine and sheep, although there is some recent information pertaining to ®sh. It is now clear from these results that when the level of circulating GH is elevated there are a number of physiological changes that occur in all the animals studied, but that in addition there are changes to phenotype that appear to be species-speci®c. The results also demonstrate that it is important to avoid consistently high levels of the hormone, identifying the need for precise regulation of the expression of the transgene. The major observations from these studies are summarized below.
The range of GH-related transgenes that have been used in domestic animals is shown in Table 1 , together with the number of transgenic animals produced and expressing these genes. Five of these genes have been designed directly on the basis of the work of Palmiter et al. (1982 Palmiter et al. ( , 1983 and consist of a GH-coding sequence joined to a regulatory sequence derived from a metallothionein (MT) gene. However, in later experiments, modi®cation to this basic design was carried out in an attempt to provide more precise control of the expression of the gene. In total, ninety-six founder transgenic pigs and thirty-®ve founder transgenic sheep have been produced, with ®fty-three of these animals expressing the inserted gene (forty-one pigs and twelve sheep).
Common to transgenic swine and transgenic sheep was a large depletion in body fat, an increase in muscle mass and an increase in the size of the visceral organs (Hammer et al. 1985; Rexroad et al. 1990; Nancarrow et al. 1991; Pursel & Solomon, 1993) . The most detailed analysis of the results obtained in transgenic swine is by Pursel & Solomon (1993) . These data show an enhanced growth rate (11Á1±13Á7 %) as long as the diet was modi®ed to contain increased levels of protein and lysine, which is consistent with results obtained in animals injected with exogenous GH (Goodband et al. 1988; Newcomb et al. 1988 ). These animals also had feed intake reduced by 17 ±20 %, resulting in an increase of 16± 18 % in the ef®ciency of converting feed into body-weight gain, again consistent with the results obtained by injecting exogenous GH into swine (Campbell et al. 1988; Evock et al. 1988) . Detailed examination of the carcass properties of these animals showed that, when separated into the four primal (pork) cuts, the hams of the transgenic animals were signi®cantly larger and the loins signi®cantly smaller than the controls, and the intramuscular fat content was greatly depleted. This reduction in fat content did not, however, appear to affect the overall tenderness of the meat. The actual lipid composition in these animals was also altered. Thus, the fatty acid pro®le consistently showed a reduction in saturated fatty acids, together with a smaller reduction in mono-and polyunsaturated fatty acids. The overall result of these changes in lipid composition was to move the fatty acid pro®le closer to a 1 : 1 : 1 relationship for saturated to monounsaturated to polyunsaturated fatty acids, a pro®le which is recommended as optimal for human health.
In contrast to the results obtained with transgenic swine, the growth rates for all the transgenic sheep except those containing the gene oMT-GH10 (see later) were either not increased or in some cases even decreased (Rexroad et al. 1990; Nancarrow et al. 1991) . This is consistent with two studies of exogenous GH administered to lambs, both of which reported no signi®cant increase in average daily gain (Muir et al. 1983; Wagner & Veenhuizen, 1988) . Interestingly, a third study found a signi®cant weight gain over controls but this did not result in an increased carcass weight (Johnson et al. 1985) .
In addition to the research conducted on domestic swine and sheep, there has been a substantial amount of research obtained with transgenic ®sh containing GH-encoding transgenes. In stable ®sh lines, these animals also exhibit increased growth rates, some of which are higher than those seen in transgenic mice. Thus, Maclean et al. (1987) showed that transgenic trout containing a MT-regulated GH-encoding gene grew 3±4Á6 times larger than controls and did not have any detectable physical abnormalities, while Du et al. (1992) showed a 2 ± 6-fold increase in the growth of Atlantic salmon containing a gene encoding a unique fusion between a chinook salmon GH-coding sequence and an antifreeze protein gene promoter from ocean pout. Subsequent studies on these latter ®sh have shown that the transgene is transmitted by Mendelian inheritance to progeny which in turn retain the increased growth-rate characteristics, with an average increase in growth of 11-fold above controls (Devlin et al. 1995 (Devlin et al. , 1998 . Studies on the physiology of these ®sh indicate that they have a 15 ±20 % increased feed conversion ef®ciency (Entis, 1997) . It is also of interest to note that the transgenic ®sh are more readily reared in conditions of temperature and photoperiod that optimize growth but which would inhibit normal smolt development and postsmolt performance of non-transgenic salmon (Saunders et al. 1998) . Several other species of transgenic ®sh have also been produced that contain modi®ed GH transgenes. The introduction of a gene-encoding salmonid GH increased the growth rate of channel cat®sh by 30 ± 40 % (Dunham & Devlin, 1998) , a gene-encoding tilapia GH increased the size of F1 progeny at 9 months of age by 82 % (Martinez et al. 1996) and a human GH-encoding gene increased feed conversion ef®ciency in carp by 30± 40 % (Fu et al. 1998) .
All the larger domestic transgenic animals produced with MT-regulated GH-encoding transgenes, with the exception of oMT-GH10, showed signi®cant health problems. In swine these included lameness, susceptibility to stress, gastric ulcers, parakeratosis, lethargy, anoestrus in gilts and lack of libido in boars (Pursel et al. 1990) . In sheep, similar severe health problems were noted, with the possible exception of gastric ulcers Rexroad et al. 1990; Nancarrow et al. 1991) . However, the transgenic sheep were prone to diabetes . In the transgenic coho salmon, the phenotype of the small and mediumsized transgenics was normal, whereas excess cranial and opercular cartilage, together with impaired swimming ability, was apparent in the animals with the high growth rates (RH Devlin, CA Biagi and DE Smailus, unpublished results).
The results obtained with MT-regulated GH-encoding genes suggested that the elevated GH caused a shift in body metabolism towards protein synthesis at the expense of fat and carbohydrates, consistent with the results obtained by exogenous administration of GH. However, sustained elevation of GH concentrations was deleterious to the health of the animals. Accordingly, attempts have been made to regulate the expression of the transgene. Various laboratories have taken different approaches to the solution of this problem. Nottle et al. (1998) introduced a MT-regulated GH-encoding transgene into 296 swine, culled all animals that showed constitutive expression of the transgene and then identi®ed from the remainder those animals that could be induced to express the GH gene by dietary Zn. Twelve animals were identi®ed, four of which did not transmit the gene and seven of which were germline mosaic animals. It thus remains to be seen if any of the germ-line mosaic animals retain the low constitutive but Zn-inducible expression when they are bred to a non-mosaic line in which all cells contain the transgene.
Another solution to improved gene regulation is to change the promoter used to drive expression of the exogenous GH or to change the hormone from GH to one of the other growthregulating peptides. The range of transgenes that have been constructed and introduced to transgenic animals is shown in Table 1 . None of these gene modi®cations appear to be any more successful than the original MT-regulated GH-encoding genes. However, a novel modi®cation to the ovine MT-GH construction, giving rise to the gene oMTSGH10, appears to be promising. This gene, oMTSGH10, is based on the gene oMTSGH9, which has been described by Shanahan et al. (1989) . oMTSGH10 has been constructed in a way that was designed to reduce the level of constitutive and inducible transcription both constitutively and when subjected to Zn induction (Ward & Brown, 1998) . In contrast to its progenitor, oMTSGH10 has very low expression in transgenic mice and shows no evidence of Zn inducibility. It has been introduced into one transgenic sheep, from which a line of animals has been made and used to examine the effects of the gene on growth rate and body composition. While some of the data are still being collected, it is already clear that the animals are in good health, grow from the age of about 4 months onwards at a rate between 15 ±20 % faster than controls, and have a much leaner carcass (Ward & Brown, 1998) . Feed utilization ef®ciency has been measured from 3Á5 months to 7 months of age and was the same as that of controls during this period. This will need to be repeated at later stages of growth. To date, the gene has only been successfully inserted into a single founder animal, from which a line of sheep has been bred through three generations. More founder animals will clearly need to be generated before it can be unequivocally concluded that the advantageous growth characteristics shown by the current line of animals are likely to be found in all animals containing the oMTSGH10 gene, but when considered together with the results obtained in transgenic mice, these results looks very encouraging.
A third approach to obtaining animals with promising growth performance is that described for pigs by Pursel et al. (1996 Pursel et al. ( , 1998 , in which the IGF-1 gene is controlled by the avian skeletal a-actin promoter. Using this transgene, expression of IGF-1 is primarily con®ned to the muscle cells and has its effect directly on this tissue. In consequence, average daily weight gain and feed ef®ciency do not differ from control animals, but the transgenic animals had 11Á4 % and 3Á3 % less fat and 5Á1 % and 2Á2 % more protein in the eviscerated carcasses of males and females respectively (Pursel et al. 1998 ). The IGF-1 concentrations of plasma were between 9 % and 10 % higher than in control pigs and the general health of the animals was good. The avian skeletal a-actin promoter has also been used in another approach recently described in mice. In this case the promoter is joined to the gene sequence encoding GH and the fusion gene inserted into mice by injecting the DNA directly into regenerating quadriceps muscle tissue. This results in the uptake of some of the DNA into the muscle cells, which then produce and secrete GRF in levels suf®cient to elevate GH and produce increased body growth (Draghia-Akli et al. 1997).
These results together indicate that the concept of increasing body growth and feed utilization ef®ciency, whilst simultaneously improving the carcass composition of domestic animals to make it more suitable for human consumption, remains a worthwhile and achievable goal. The dif®culty that must still be overcome is the adverse effect on health that results in animals that produce GH at high levels. However, optimization of GH-encoding genes is progressing to the stage where transgenic animals with genuine commercial application are close to reality and might be expected to be in ®eld trials within the next few years. Whether the time taken by this series of projects can be used as a guide to the length of time that any transgenic project might require to progress from initial concept to commercial reality is uncertain, because the technology is maturing at a fast rate and should be enhanced substantially by nuclear transfer as an improved method for the production of transgenic animals. Nevertheless it is clear from the GH research which commenced in domestic animals in about 1984 that transgenic animal research projects are long-term and high-risk and are likely to remain so for some time yet.
The modi®cation of intermediary metabolism
The evolution of domestic animals has been a complex procedure involving both natural selection and the selection of speci®c traits aimed at increasing the production of various animal products. However, these two different selection processes do not necessarily work harmoniously together. Natural selection produces animals that are generally well adapted for survival in their natural environment, while selection for speci®c productivity traits is less concerned with this outcome provided that the animals are compatible with the more controlled production environment in which they are placed. Since the biosynthesis of nutrients requires an input of energy, it is not surprising that metabolic pathways for the synthesis of many of the compounds that are readily available from feed supplies are frequently lost during an evolutionary process driven by natural selection. However, when such animals become the genetic base for the selection for speci®c production traits, their restricted biosynthetic capability can result in a speci®c nutrient becoming a limiting factor for production. One of the more useful features of transgenic technology is its ability to replace missing biosynthetic pathways in animals by transferring to them the relevant functional genes isolated from some other organism. Since much of intermediary metabolism is common across all organisms, prototrophic bacteria are an excellent source for these functional genes because they retain the ability to synthesize most of the compounds of intermediary metabolism. Furthermore, there is now a signi®cant body of evidence accumulating to show that the bacterial enzymes encoded by these genes can have acceptable levels of activity in mammals. Most research in this area so far has been directed towards the goal of increasing the supply of essential amino acids, particularly cysteine, threonine and lysine. However, some progress has also been made towards the introduction of a functional glyoxylate cycle in animals. Of these projects, only the work directed towards the introduction of a functional cysteine biosynthetic pathway has yet reached the stage of being tested in domestic animals. Because it is the most advanced of the current projects, it will be discussed in some detail. However, the general principles inherent in this project apply in general to most projects aimed at introducing new biosynthetic pathways to animals.
Amino acid biosynthetic pathways. The replacement of the biosynthetic pathways for some of the essential amino acids has received considerable attention because these are frequently rate-limiting nutrients for speci®c production traits. For example, in sheep under some pasture conditions the amino acid cysteine is rate-limiting for wool growth and it has been predicted that wool growth could be increased substantially if this amino acid were freely available (Reis, 1979) . Because most ingested nutrients are rapidly metabolized by the rumen micro¯ora in sheep, the simple procedure of feeding additional cysteine to de®cient animals is not effective (Reis, 1979 ) and the sheep is lacking the genes necessary for the enzymes of cysteine biosynthesis. The relevant biosynthetic pathway in Escherichia coli is shown in Fig. 1 . It can be broadly divided into a pathway for the reduction of S to an active form of reduced sul®de and a C pathway in which, ®rstly, the amino acid serine is converted to O-acetylserine in the presence of acetyl-CoA and the enzyme serine transacetylase (EC 2.3.1.30; SAT), and then the O-acetylserine is converted to cysteine in the presence of sul®de and the enzyme O-acetylserine sulfhydrylase (EC 4.2.99.8; OAS). The sul®de concentration in the sheep rumen has been reported to be in the range of 0Á6 to 288 mgaml (Bray & Till, 1975) , suggesting that a functional biosynthetic pathway might be possible in sheep if the enzymes SAT and OAS could be provided in the ruminal epithelial cells.
In E. coli the cysE gene encodes the enzyme SAT and the cysK or cysM genes encode variants of the enzyme OAS. Accordingly, the cysE (Denk & Bock, 1987) and cysK (Byrne et al. 1988 ) genes were isolated and modi®ed for expression in eukaryotic organisms (Leish et al. 1993) . This is a crucial step in any project involving the transfer of genes from bacteria to mammals and the requirements for strong expression of the transgenes in animals is still only partially understood. Brie¯y, a promoter must be linked 5
H to the bacterial coding sequence such that it will direct expression of the gene in appropriate tissues and a DNA sequence encoding a suitable polyadenylation signal must be linked 3 H to the coding sequence. For the formation of a functional cysteine biosynthetic pathway, the structure of the gene MTCEK1 is shown in Fig. 2 . This gene embodies the general principles involved in altering a bacterial gene sequence to a functional eukaryotic gene. Various other constructions have also been made and tested and these are summarized in Leish et al. (1993) .
The ability of the gene MTCEK1 to provide a functional cysteine biosynthetic pathway in mammals has been demonstrated in several different ways. Initial testing of the gene was carried out in eukaryotic cells, demonstrating that the bacterial enzymes could be synthesized at Fig. 1 . The carbon pathway portion of the cysteine biosynthetic pathway in E. coli. Fig. 2 . The gene MTCEK1 which encodes the cysteine biosynthetic pathway shown in Fig. 1. 
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high levels in that they were very active and stable in such cells Leish et al. 1993) . The gene was then introduced into transgenic mice where it was shown to be expressed at high levels in several tissues including the small intestine (Ward et al. 1994) . When this intestinal tissue was incubated with sul®de, the synthesis of cysteine was clearly demonstrated. The most convincing demonstration of the functionality of the cysteine pathway in transgenic mice, however, was obtained by a dietary study in which transgenic mice and appropriate control mice were placed on a synthetic diet which was supplemented with Na 2 S but in which the sulfur amino acids cysteine and methionine were reduced in concentration to low levels. After 7 d on this diet, substantial hair loss and weight loss were experienced by the control animals but the transgenic animals continued to grow normally and did not lose any hair (Ward et al. 1994) . One of the crucial requirements for the modi®cation of animal biochemistry is that the new pathway be compatible with the existing intermediary metabolism of the animal. In the case of the transgenic mice containing the gene MTCEK1, the new cysteine biosynthetic pathway apparently integrates with the animal's existing biochemistry without any dif®culty. On the other hand, the pathway appears to be less compatible with the existing intermediary metabolism of sheep. A summary of the results obtained in our own laboratory and that of Rogers and colleagues (Sivaprasad et al. 1992; Bawden et al. 1995) is provided by Ward et al. (1998) . Brie¯y, these show that twenty-eight transgenic sheep with the genes encoding cysteine biosynthesis have been produced. These animals contain the bacterial coding sequences for the enzymes SAT and OAS, isolated either from E. coli or from Salmonella typhimurium (Sivaprasad et al. 1992) and regulated by three different eukaryotic promoters. However, no useful expression of the genes has been obtained in any of these animals, although some low-level expression has been detected Ward et al. 1998) . In addition, the number of transgenic animals produced as a percentage of embryos microinjected is low compared with the ef®ciency obtained for other genes (Ward et al. 1998 ). An obvious explanation for these results is that high levels of expression of a cysteine biosynthesis pathway in sheep embryos is lethal, so that the only transgenic animals obtained are those in which the genes have been inserted in a region of the genome that prevents their expression or at best allows only low levels of expression. Two possible explanations have been put forward to explain these results. The ®rst is that during embryogenesis an unacceptable depletion of the co-factor acetyl-CoA occurs as a result of the unregulated operation of the ®rst step of the pathway involving serine and acetyl-CoA (Ward et al. 1998 ). This step is catalysed by the enzyme SAT, which is inhibited by high levels of cysteine. However, normal intracellular levels of cysteine are low and sul®de levels in the embryo would be expected to be insigni®cant, thus preventing the operation of the full pathway proceeding to cysteine biosynthesis. The SAT would therefore be free to operate in an unregulated manner without any product inhibition. Acetyl-CoA is unlikely to be in short supply in an adult ruminant because the abundant supply of acetate produced by the rumen micro-organisms is readily converted to acetyl-CoA by the enzyme acetylCoA synthase (EC 6.2.1.1) (Van Soest, 1982) . However, this is not the case in the embryo during early development because, as found in most mammalian embryos, acetyl-CoA synthase activity is very low (Waugh & Wales, 1993 ). This does not cause any dif®culties in embryos which can convert glucose to lactate, but this option is blocked in the ruminant blastocyst by a low activity of the enzyme pyruvate kinase (EC 2.7.1.40) (Rieger & Guay, 1988) . The developing ruminant is therefore critically dependent on the introduction of oxidizable substrates to the tricarboxylic-acid cycle and in consequence a fully-functional tricarboxylic-acid cycle to deal with them. The unregulated operation of SAT in the cytoplasm of these embryos would be expected to lower cytoplasmic and hence mitochondrial acetyl-CoA levels and such depletion might reasonably be expected to affect adversely the energy supply to the developing embryo.
The other possible explanation is that the pathway is fully operational in the embryo allowing toxic levels of free cysteine to accumulate in the cells . While this would appear less likely because of the lack of sul®de in the embryo, it can nevertheless not be excluded at present. Regardless of which explanation is correct for the dif®culties experienced in duplicating, in sheep, the functionality of the pathway that was obtained in transgenic mice, it is clear that several possibilities need to be examined. On the assumption that the pathway is not totally incompatible with the intermediary metabolism of adult ruminants, a promoter needs to be found that regulates expression of the genes only to the rumen epithelium and which also prevents such expression until after the birth of the animal.
While the research directed towards the introduction of a cysteine biosynthetic pathway is the most advanced example of the use of genetic engineering to modify the intermediary metabolism of an animal, several other projects are in earlier stages of development. One of these is the proposal to introduce the pathways for the biosynthesis of the amino acids threonine and lysine to non-ruminants (Rees et al. 1990) , since these amino acids need to be added to cereal protein for maximal utilization. An interesting and valuable aspect of this paper was the use of computer simulation to predict the¯ux of biosynthetic products produced by the introduction of a novel pathway to an animal. However, the general concepts of the cysteine biosynthesis project described earlier are equally applicable to threonine and lysine, but the pathways are more complex and this raises some logistical problems. In contrast to the relatively simple two-gene pathway required for cysteine biosynthesis, the biosynthesis of threonine involves four genes and that of lysine a minimum of eight genes. Because the objective becomes more complex as the number of genes increases, the introduction of a threonine pathway by the same strategy as that adopted for the cysteine biosynthesis pathway would be dif®cult, while the introduction of a lysine biosynthesis pathway would be unlikely to succeed. The main problem encountered in the construction of multi-enzyme pathways is the technical dif®culty of modifying each bacterial gene to replace its bacterial promoter sequence with an appropriate eukaryotic promoter and then assembling the genes into a single piece of DNA in preparation for gene transfer. Several novel approaches to overcome some of the dif®culties associated with pathways requiring large gene numbers have been proposed. In order to overcome the need for multiple promoters within a multi-gene complex, the coding sequences for each of the required enzymes can be fused to provide a single DNA sequence encoding the required polypeptides under the control of a single eukaryotic promoter. There are two ways in which the desired enzymic activities can be obtained from the mRNA transcript of such multifunctional DNA sequence. The ®rst invokes the use of the encephalomyocarditis virus internal ribosomal entry site DNA sequence which, interspersed between two coding sequences of a single mRNA, allows the initiation of translation to occur both at the start of the mRNA and also internally within the mRNA, resulting in the production of two separate polypeptides. Initially described by Kim et al. (1992) , this concept has been subjected to signi®cant commercial development and a number of vectors are now available providing considerable¯ex-ibility in the construction of appropriate DNA sequences. The disadvantage of internal ribosomal entry sites is the signi®cant reduction in translation of the downstream polypetide compared with the upstream protein, making the approach inappropriate for those situations where the desired enzymic activities need to be present at similar levels. The alternative approach that is receiving considerable attention is the production of a single polypeptide which folds to a tertiary structure that provides several catalytic sites (for references, see Robinson & Sauer, 1998) . This ®eld is progressing rapidly as structure ±function predictions of proteins become more sophisticated and promises to be an effective way of reducing the amount of DNA required to encode metabolic pathways. A closely related example in plants consists of a three-enzyme complex designed to catalyse a portion of the mannityl opine biosynthetic pathway complex (von Bawden et al. 1995) . The gene was constructed by fusing the relevant coding sequences together and placing a single strong plant promoter at the 5 H end of the complex. Each coding sequence was separated by a short DNA sequence encoding the recognition sequence for a site-speci®c protease. In addition, the coding sequence for the actual protease required for the recognition of these cleavage sites was also included in the multi-gene tandem array. This elegant construction produces a single polypeptide translation product which is then cleaved in cis by the encoded protease to give rise to the separate enzyme proteins which were able to catalyse the appropriate reactions. A combination of this approach and fusion peptides which are multi-functional, without the need for proteolytic cleavage, would be able to catalyse complex pathways. It will be interesting to follow up this research with studies to determine how many enzymes can be encoded in a single piece of DNA in this way.
The glyoxylate cycle. While the introduction of biochemical pathways for the biosynthesis of essential amino acids is receiving most attention at present, a challenging project is also in progress aimed at introducing a functional glyoxylate cycle to ruminants (Byrne, 1990; which would allow such animals to synthesize glucose from the abundant supplies of acetate they receive from the rumen. Ruminants are substantially less ef®cient in their utilization of feedstuff compared with single-stomached animals and one of the major reasons for this is thought to be the lack of glucose available to them for direct absorption from the gut (Bergman, 1975; Van Soest, 1982) . There are several tissues in ruminants that could conceivably bene®t from the ability to synthesize glucose directly from acetate. These include the mammary epithelium, due to the high carbohydrate content of milk, and the sheep wool follicle, which has an extremely active pentose phosphate pathway thought to be involved in the maintenance of the cellular redox potential during keratin protein biosynthesis (Chapman & Ward, 1979) .
A functional glyoxylate cycle requires the presence of two enzymes, isocitrate lyase (EC 4.1.3.1) which cleaves isocitrate to succinate and glyoxylate, and malate synthase (EC 4.1.3.2), which catalyses the fusion of glyoxylate and acetyl-CoA to form malate . The aceA and aceB genes of E. coli encode these two enzymes and both genes have been isolated, characterized and assembled into a fusion gene construct MTAceAB1 (Byrne, 1990) which is similar in structure to that of the gene MTCEK1 encoding cysteine biosynthesis (Leish et al. 1993) (Fig. 2) , except that the cysE and cysK coding sequences have been replaced by the aceA and aceB coding sequences. This DNA has been introduced into mammalian cells in culture and shown to be actively transcribed and translated into the appropriate enzymes (Byrne, 1990; , a valuable piece of information that demonstrates that the glyoxylate cycle can apparently co-exist with existing biochemistry in a mammalian cell without sequestering the new enzymes in speci®c organelles. The same gene has also been inserted into transgenic mice and has been shown to be expressed in a variety of tissues including the liver and small intestine (Saini et al. 1996) . The level of expression in these animals was not as high as that found for the gene MTCEK1 and the reason for this is not yet known. It may be that more animals have to be produced in order to generate one with a high level of expression. However, it is interesting that attempts in our laboratory to insert the gene into sheep have been unsuccessful so far. It is conceivable that high expression of a glyoxylate cycle in an animal may not be well tolerated, in which case the gene will need to be constructed with promoters that can be regulated and which can direct expression to speci®c tissues such as the mammary epithelium, the ruminal epithelium and the skin, where the increased production of glucose might be advantageous. This research will bene®t from the nuclear transfer technology as it matures into a useful method for transgenic animal production, because the pathway can be introduced and examined for functional integration within its new genome before its transfer to animals.
The modi®cation of digestion
The process of digestion, particularly in non-ruminants, provides another potential target for modi®cation by transgenic techniques. The intestinal tract offers numerous targets, one of the most attractive being the secretion of novel degradative enzymes into the digestive system to provide a mechanism for the utilization of feedstuffs that normally escape digestion and absorption. Obvious substrates are dietary cellulose and xylan, which are inef®ciently degraded in non-ruminants by microbial fermentation in the hindgut. It follows that the introduction of cellulase (EC 3.2.1.4) activity into the small intestines of non-ruminants would signi®cantly enhance the nutrient value of plant-based feedstuffs to these animals (Hazlewood et al. 1989; Forsberg et al. 1993 ).
An innovative research programme has been initiated in this area and has made signi®cant progress towards the eventual modi®cation of domestic animals, summarized as follows. The enzyme chosen for introduction to the digestive tract was the bacterial endoglucanase E (EC 3.2.1.6) from Clostridium thermocellum. After isolation and characterization of the appropriate bacterial enzyme, an important step in this work was the demonstration that a truncated form of this enzyme could be secreted by eukaryotic cells in an enzymically active conformation (Hall et al. 1988 (Hall et al. , 1990 Soole et al. 1993) . The DNA encoding this enzyme was then fused to a pancreas-speci®c enhancer region of the elastase I (EC 3.4.21.36) gene and inserted into the genomes of transgenic mice. These animals produced the truncated cellulase mRNA only in the pancreas and secreted enzymically active cellulase protein into the small intestine . This is a ®nding of some signi®cance to the concept of digestion modi®cation, because it demonstrates not only that the bacterial enzyme is stable in the environment of the small intestine but that a mechanism has been discovered for the secretion of heterologous proteins from the exocrine pancreas into the lumen of the small intestine.
The level of expression of the cellulase in the transgenic mice reported by Hall et al. (1993) appears too low to provide signi®cant improvement in the digestion of an animal and the project is currently in the process of increasing the level of expression to that approximating the expression of the normal elastase I gene (Ali et al. 1995) . This is reminiscent of the work required for the introduction of the cysteine biosynthetic pathway to animals, which required the construction of a range of gene variants in order to obtain one with suf®cient expression in transgenic mice. It is also of interest to note that, just as for the bacterial genes of the cysteine biosynthetic pathway and the glyoxylate cycle, the introduction of intron sequences into the cellulase gene construct did not improve the level of expression in mice. This may thus prove to be a feature of many bacterial genes as they are expressed in mammalian cells.
Conclusions
Transgenic techniques offer a wide range of possibilities for the improvement of nutrient utilization in domestic animals, but it has yet to be demonstrated that any of these can be brought to fruition. There are, however, several projects that appear to be making progress towards this goal. The most advanced are those that involve the modi®cation of growth and carcass composition by the introduction of transgenes that alter the level of circulating hormones involved in the control of body growth. Judged by current rates of progress, it is possible that genetically modi®ed pigs and sheep could be in ®eld trial within the next few years. This will undoubtedly stimulate some debate within the community about the suitability or otherwise of genetically modi®ed meat for human consumption, if the debate currently in progress concerning genetically modi®ed plant foods is any guide. However, the improved carcass composition of such animals is likely to be an appealing feature to the consumer and the improved feed utilization ef®ciency would be attractive to the producer.
The introduction to the farm environment of animals with modi®ed biochemical properties is still in the research phase and likely to remain at this point for at least the next 5 years. It is apparent that new pathways interacting with existing intermediary metabolism can be introduced to animals, but the results obtained when the cysteine biosynthetic pathway was moved from mice to sheep demonstrates the species-speci®c dif®culties that can ensue. At present, the introduction of the cysteine biosynthetic pathway to sheep appears to be the project closest to application, but there remain several crucial areas of research yet to be completed before this can take place. The introduction of the glyoxylate cycle to ruminants is much further from completion but holds the promise of a greater long-term impact on animal agriculture. As mathematical models become more sophisticated in their ability to predict performance on the basis of feed intake, it will be valuable to attempt to model the expected impact of a glyoxylate cycle on ruminant performance.
A major stimulus to the current application of transgenic techniques to agriculture will come from the recently developed methods of nuclear transfer and animal cloning. These techniques allow the introduction and preliminary testing of DNA constructions in cells in culture and then to use such cells to produce viable animals containing the recombinant DNA. It has been apparent for some years that the ability to produce whole organisms from cultured cells has been one of the major advantages held by those scientists working with plants compared with those working with animals, allowing the genetic modi®cation of plants to proceed very quickly in recent years. As we face the challenges of an expanding food demand in the next several decades, the ability to accelerate the genetic modi®cation of animals will be of vital importance.
It is clear that there are signi®cant areas of nutritional physiology that are still only partially understood. There remains much to be discovered concerning the detailed interaction of nutrients in the intermediary metabolism of ruminants. Transgenic animals may help to shed some light on these problems and, in return, a better understanding might identify additional genetic alterations relevant to the improvement of productivity. It will be interesting to observe progress over the next 5 years as the new techniques in the area of transgenesis are brought to bear on these issues.
